Combination Therapy for MRSA Bacteremia: To ß or Not to ß?
Publication
, Journal Article
Holland, TL; Davis, JS
Published in: Clin Infect Dis
June 24, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
June 24, 2020
Volume
71
Issue
1
Start / End Page
11 / 13
Location
United States
Related Subject Headings
- beta-Lactams
- Staphylococcal Infections
- Retrospective Studies
- Microbiology
- Methicillin-Resistant Staphylococcus aureus
- Humans
- Daptomycin
- Cohort Studies
- Bacteremia
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holland, T. L., & Davis, J. S. (2020). Combination Therapy for MRSA Bacteremia: To ß or Not to ß? Clin Infect Dis, 71(1), 11–13. https://doi.org/10.1093/cid/ciz750
Holland, Thomas L., and Joshua S. Davis. “Combination Therapy for MRSA Bacteremia: To ß or Not to ß?” Clin Infect Dis 71, no. 1 (June 24, 2020): 11–13. https://doi.org/10.1093/cid/ciz750.
Holland TL, Davis JS. Combination Therapy for MRSA Bacteremia: To ß or Not to ß? Clin Infect Dis. 2020 Jun 24;71(1):11–3.
Holland, Thomas L., and Joshua S. Davis. “Combination Therapy for MRSA Bacteremia: To ß or Not to ß?” Clin Infect Dis, vol. 71, no. 1, June 2020, pp. 11–13. Pubmed, doi:10.1093/cid/ciz750.
Holland TL, Davis JS. Combination Therapy for MRSA Bacteremia: To ß or Not to ß? Clin Infect Dis. 2020 Jun 24;71(1):11–13.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
June 24, 2020
Volume
71
Issue
1
Start / End Page
11 / 13
Location
United States
Related Subject Headings
- beta-Lactams
- Staphylococcal Infections
- Retrospective Studies
- Microbiology
- Methicillin-Resistant Staphylococcus aureus
- Humans
- Daptomycin
- Cohort Studies
- Bacteremia
- 3202 Clinical sciences